Flow_cytometric_determination_of_the_multidrug_resistant_phenotype_in_transitional_cell_cancer_of_the_bladder:_implications_and_applications._We_detail_our_experience_with_a_monoclonal_antibody_to_detect_the_cell_surface_P-glycoprotein_product_of_the_multidrug_resistance_gene_(MDR-1)_in_the_human_bladder._A_total_of_32_patients_had_44_different_specimens_analyzed._The_samples_consisted_of_8_normal_bladders,_21_transitional_cell_carcinomas,_1_mucinous_adenocarcinoma,_3_P-0_bladder_wall_specimens_and_10_nonmalignant_urothelial_samples_from_cystectomies._P-glycoprotein_was_not_detected_in_the_normal_adult_or_pediatric_bladder._Bladder_specimens_from_3_children_with_a_neurogenic_bladder_revealed_enhanced_expression_(21%,_14%_and_4%_positivity)._Transitional_cell_carcinoma_usually_demonstrates_low_expression_at_diagnosis_(less_than_6%),_although_3_patients_had_enhanced_initial_expression_(11%,_12%_and_31%)._Three_patients_treated_with_chemotherapy_demonstrated_56%,_76%_and_50%_expression_of_MDR-1._Nonmalignant_tissue_from_cystectomy_specimens_had_low_expression_of_MDR-1._The_specificity_of_this_system_was_confirmed_with_human_bladder_cell_lines._The_ability_of_flow_cytometry_to_detect_and_quantify_the_expression_of_MDR-1_may_allow_for_the_early_detection_of_chemotherapy_resistance_in_patients_with_transitional_cell_carcinoma_treated_with_systemic_and_intravesical_therapy.